BRCA mutations, Lynch syndrome, Li-Fraumeni syndrome, and other hereditary cancer syndromes create environments where additional risk factors deserve careful consideration
These peptides are primarily intended for research purposes, and while they show good results in prostate cancer cell lines and in vivo studies, their use in humans should not be undertaken without proper medical supervision and clinical trials
This does not necessarily mean the peptide is dangerous, but it means stated purity numbers should be taken with a grain of salt unless verified independently
The mean age of female patients with abnormal results was 49 years in the public system and 44 years in the private system
Regarding plasma B12 - this is not the case, serum B12 often remains highly elevated (well over the normal range) even while symptoms return - this is why testing B12 once treatment begins is not recommended
Studies show that B12 has a role in keeping nerves healthy and supporting brain function when there is a deficiency